Additional KIF6 Risk Offers Better Adherence to Statins

Completed

Conditions studied: Cardiovascular Diseases, Dyslipidemia

In brief

Many patients prescribed statins to lower their cholesterol stop taking their statin over time. The purpose of this study is to determine whether providing subjects their KIF6 carrier status (associated with increased cardiovascular event risk) will improve adherence to statin medications.

Key facts

Study ID

NCT01068834

Run by

Medco Health Solutions, Inc.

People needed

1282

Starts

2010-03-01

Expected to finish

2011-04-01

Last updated by the study team

2012-02-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women at least 18 years of age
• New statin prescription
• Medco RationalMed® Program
• Data contains patient contact information (e.g. phone number)
• Data contains provider contact information
• Willing to sign informed consent and send KIF6 test results to their provider

You may not qualify if…

• Statin prescription in the previous 6 months
• Subject refusal to participate in this study (record reason from subject)
• Physician refusal to participate in this study (record reason from provider)
• Anticipated statin discontinuation within 6 months
• Any condition that would prevent the subject from completing the 6 month study follow-up period
• Subject with "no contact red flag"
• Subject residing in NY, NJ, MA, PA

Where it is running

• Medco Health Solutions, Inc — Franklin Lakes, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.